Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Green synthesized silver nanoparticles from Moringa: Potential for preventative treatment of SARS-CoV-2 contaminated water

  • Omorilewa B. Ebunoluwa,

    Roles Data curation, Investigation, Methodology, Resources, Writing – original draft, Writing – review & editing

    Affiliation Department of Cell Biology and Genetics, University of Lagos, Yaba, Lagos, Nigeria

  • Adebayo J. Bello,

    Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

    Current Address: School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, United Kingdom

    Affiliation Department of Biological Sciences, Redeemer’s University, Ede, Osun, Nigeria

  • Rukayat O. Ayorinde,

    Roles Data curation, Investigation, Methodology, Writing – original draft, Writing – review & editing

    Affiliation Department of Biological Sciences, Redeemer’s University, Ede, Osun, Nigeria

  • Nneka Onyejepu,

    Roles Data curation, Investigation, Methodology, Supervision, Validation, Writing – review & editing

    Affiliation Centre for Tuberculosis Research, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria

  • Joseph O. Shaibu,

    Roles Data curation, Investigation, Methodology, Resources, Validation, Writing – review & editing

    Affiliation Centre for Human Virology and Genomics, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria

  • Adeniyi R. Adewole,

    Roles Data curation, Investigation, Methodology, Writing – review & editing

    Affiliation Chevron Molecular Biology Research Laboratory, College of Medicine, University of Lagos, Yaba, Lagos, Nigeria

  • Abeebat O. Adewole,

    Roles Data curation, Investigation, Methodology, Resources, Writing – review & editing

    Affiliation Department of Biomedical Science, Teesside University, Middlesbrough, United Kingdom

  • Olusegun A. Adedeji,

    Roles Data curation, Investigation, Methodology, Writing – review & editing

    Affiliation Department of Biological Sciences, Redeemer’s University, Ede, Osun, Nigeria

  • Ololade O. Akinnusi,

    Roles Formal analysis, Writing – review & editing

    Affiliation Department of Nursing and Community Health, Glasgow Caledonian University, Glasgow, United Kingdom

  • Olajumoke B. Oladapo,

    Roles Data curation, Formal analysis, Writing – review & editing

    Affiliation Department of Cell Biology and Genetics, University of Lagos, Yaba, Lagos, Nigeria

  • Temitope S. Popoola,

    Roles Formal analysis, Resources, Writing – review & editing

    Affiliation Department of Cell Biology and Genetics, University of Lagos, Yaba, Lagos, Nigeria

  • Oluwamodupe M. Arotiba,

    Roles Investigation, Methodology, Writing – review & editing

    Affiliation Chevron Molecular Biology Research Laboratory, College of Medicine, University of Lagos, Yaba, Lagos, Nigeria

  • Joseph B. Minari,

    Roles Project administration, Resources, Supervision, Writing – review & editing

    Affiliation Department of Cell Biology and Genetics, University of Lagos, Yaba, Lagos, Nigeria

  • Luqman A. Adams,

    Roles Project administration, Supervision, Validation, Writing – review & editing

    Affiliation Department of Chemistry, University of Lagos, Yaba, Lagos, Nigeria

  • Joy Okpuzor,

    Roles Project administration, Resources, Supervision, Validation, Visualization, Writing – review & editing

    Affiliation Department of Cell Biology and Genetics, University of Lagos, Yaba, Lagos, Nigeria

  •  [ ... ],
  • Mujeeb O. Shittu

    Roles Project administration, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

    mujeebsh@buffalo.edu

    Affiliation Department of Biotechnical and Clinical Laboratory Science, Jacobs School of Medicine and Biomedical Sciences, The State University of New York (SUNY), University at Buffalo, Buffalo, New York, United States of America

  • [ view all ]
  • [ view less ]

Abstract

Biogenic silver nanoparticles have been reported as good antimicrobial candidates. In this study, we synthesized and characterized silver nanoparticles using aqueous leaf extracts of Moringa oleifera (AgNPmo) and investigated their antimicrobial and antiviral activities. The AgNPmo demonstrated antibacterial activity against Pseudomonas aeruginosa and Staphylococcus aureus, with concentration-dependent zones of inhibition ranging from 6.5–15.5 mm and 0–7 mm, respectively. Cytotoxicity was assessed on Vero cells using a CCK-8 assay, which revealed an IC50 value of 38 µg/ml, indicating relatively low toxicity at effective concentrations. The antiviral activity against SARS-CoV-2 was confirmed using quantitative RT-PCR: AgNPmo exposure led to a time- and dose-dependent increase in Ct values for ORF1ab and N genes, with the strongest inhibition observed after 48 h. These results provide direct evidence of both antimicrobial and antiviral activity. The green synthesis using Moringa extracts offers added advantages by employing phenolic and flavonoid compounds as natural reducing and capping agents, making the process eco-friendly and biocompatible. While direct wastewater treatment was not tested, these findings highlight the advantages of Moringa leaf extract as a natural reducing and capping agent that enabled rapid, eco-friendly AgNP formation, while the resulting AgNPmo demonstrated antimicrobial and antiviral activity. Thus, AgNPmo represents a promising, sustainable option for point-of-use disinfection and potential environmental water treatment.”.

Introduction

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the causative agent of a contagious, life-threatening disease called Coronavirus-2019 (COVID-19) [1,2]. So far, SARS-CoV-2 has spread globally to all continents since the World Health Organization (WHO) proclaimed it a Public Health Emergency of International Concern (PHEIC) in January 2020, with more than 775 million illnesses and more than 7 million deaths confirmed as of May 2024 according to COVID-19 dashboard on World Health Organisation website. The challenges and impacts of the disease on human health, economy, and environment have led to a plethora of studies that are focused on establishing ways of curtailing the various transmission routes of the COVID-19 virus [3].

One of the undermined transmission routes is by water contaminated with virus-infected human bodily excreta [4], and the virus is found to persist for seven days at 23°C [5]. SARS-CoV-2 virus prevalence in wastewater has been documented to pose a risk for the transmission of COVID-19 [6,7]. Also, the virus has been found in the human gastrointestinal system [8], which can be shed via faeces and may subsequently find its way into water bodies, especially from medical wastewater, wastewater from cruise ships and aircraft that are not properly managed [9]. This can lead to a developing problem, as water bodies or their components may serve as an overlooked medium for transmission of the SARS-CoV-2 virus and other viral infections. This study attempts to address this problem in a cost-effective way and could serve as a potential solution to eradicate SARS-CoV-2 in water bodies, therefore halting or slowing down the infection rate [10].

Silver nanoparticles (AgNPs) have become significantly important among other metal nanoparticles (NPs) due to their distinctive size, morphology, and environment-dependent properties, which are different from other materials’ bulk properties [11,12]. AgNPs have been used extensively as antimicrobial agents. Different studies have reported the properties and efficacy of these AgNPs against bacteria [1315], fungi [16,17], and viruses [1820]. The efficacy of AgNPs against microbes is due to the physicochemical properties of AgNPs, such as small particle size and high surface-area ratio, which enable their movement through cellular membranes to the target sites [18,21,22]. Also, the easy movement of AgNPs into living cells causes accumulation, which can lead to toxic effects at very low concentrations [23]. Hence, the biosynthesis of the nanoparticles provides eco-friendly and bio-compatible alternatives for microbial treatments.

This study focuses on the use of AgNPs biosynthesized from Moringa oleifera as a disinfectant for treating SARS-COV-2-infected water. Moringa oleifera Lam (drumstick tree), belonging to the family Moringaceae, is among the most useful medicinal trees in most of Asia and Africa. Moringa oleifera leaf extracts possess biocompounds with antioxidant and antibacterial activities [24]. These compounds act against the growth of gram-positive and gram-negative bacteria [25]. The biocompounds extracted from Moringa oleifera leaves also act as reducing and capping agents in the synthesis of silver nanoparticles [14], making them attractive antimicrobial agents. Moringa extracts have demonstrated efficacy in synthesizing metallic nanoparticles, providing a nontoxic and biocompatible approach [26]. Different parts of the Moringa plant, including leaves, seeds, and bark, possess a diverse array of bioactive compounds, making them suitable for green synthesis applications. The plant’s inherent medicinal properties can enhance the antimicrobial and anticancer properties of nanoparticles, highlighting the potential of utilizing medicinal plants in the synthesis of nanomaterials [27]. The use of Moringa extracts in the synthesis of silver nanoparticles holds particular promise for water treatment applications due to the plant’s inherent antimicrobial properties and wide availability. Green synthesis using plant extracts is a unique, systematic, affordable, and environmentally sound method for synthesizing nanoparticles with selective and specific properties and applications [28]. This is achieved through single-step processing, which is advantageous over chemical methods that use harmful and toxic chemicals [29,30]. Plant-based synthesis is environmentally benign because it uses less energy and creates less waste.

Moringa extracts have demonstrated efficacy in synthesizing metallic nanoparticles, providing a nontoxic and biocompatible approach [26]. Different parts of the Moringa plant, including leaves, seeds, and bark, possess a diverse array of bioactive compounds, making them suitable for green synthesis applications. The plant’s inherent medicinal properties can enhance the antimicrobial and anticancer properties of nanoparticles, highlighting the potential of using medicinal plants in synthesizing nanomaterials [27]. The use of Moringa extracts in the synthesis of silver nanoparticles holds particular promise for water treatment applications due to the plant’s inherent antimicrobial properties and wide availability. Green synthesis using plant extracts is a unique, systematic, affordable, and environmentally sound method for synthesizing nanoparticles with selective and specific properties and applications [28]. This is achieved through single-step processing, which is advantageous over chemical methods that use harmful and toxic chemicals [29,30].

Furthermore, plant-based synthesis is environmentally benign because it uses less energy and creates less waste. The green synthesis of silver nanoparticles using Moringa extracts offers a sustainable and environmentally friendly approach to water disinfection, with potential applications in point-of-use water treatment systems and large-scale water purification plants. Silver nanoparticles were successfully synthesized in this study using aqueous leaf extracts of the plant Moringa oleifera, and characterized using UV-Vis spectroscopy, Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), and X-ray diffractometry (XRD). The successful testing of the silver nanoparticles (AgNPs) was first carried out on clinical bacterial isolates to ascertain their antimicrobial properties. In this study, the AgNPmo showed a dose-and-time-dependent antiviral activity against SARS-CoV-2, showing that the AgNPmo has the potential to be used for the purification or treatment of SARS-CoV-2 contaminated water without exhibiting toxicity against living cells.

Results and discussion

The search for effective treatments and preventive measures against SARS-CoV-2 is still ongoing, and continuous progress in this search is pertinent to minimize the spread of the virus in water and water bodies [5,31]. Silver nanoparticles (AgNPs) have recently been studied as potential antiviral agents due to their unique properties [32]. They have been shown to exhibit antiviral activities against several viruses, including influenza [33], HIV [34], and SARS-CoV-2 viruses [20].

Thus, this study aimed to assess the effectiveness of dose-dependent biogenic silver nanoparticles against SARS-CoV-2 in an aqueous environment over a period of time. The silver nanoparticles (AgNPmo) were synthesized using Moringa oleifera and characterized using UV-Vis spectroscopy, FT-IR, scanning electron microscopy (SEM), Energy-dispersive X-ray spectroscopy (EDX), and X-ray diffraction. The AgNPmo was first tested against clinical isolates of Staphylococcus aureus and Pseudomonas aeruginosa to ascertain its efficacy. Then, a cytotoxicity test was conducted on VeroE6 cells to determine the IC50 for the subsequent antiviral assay. The antiviral activity of AgNPmo against SARS-CoV-2 was conducted using qPCR assay in a dose and time-dependent manner.

UV-visible analysis of the AgNPmo

The AgNPmo synthesis was first carried out using Moringa oleifera leaf extracts. Previous reports have shown that M. oleifera can serve as a reducing and capping agent in the synthesis of silver nanoparticles [35,36], and the derived nanoparticles can act effectively against bacteria and viruses [14,36,37]. In our study, the synthesis of AgNPmo was first ascertained visually by the color change of the reaction mixture, changing from yellowish to dark brown within 5 minutes (Figure in S2 Fig). The UV-Vis spectroscopy revealed a characteristic absorption peak at 420 nm (red line), indicating the formation of AgNPmo (Fig 1).

thumbnail
Fig 1. Spectrophotometry analysis of the biosynthesized silver nanoparticles.

The analysis immediately after the synthesis of AgNPmo (red line) and analysis after 12 months of synthesis (blue line) show similar peaks, indicating the long-term stability of AgNPmo. A major absorption peak at 420 nm corresponds to the AgNP surface plasmon resonance.

https://doi.org/10.1371/journal.pone.0338800.g001

The observed absorbance peak wavelength is typical of silver nanoparticles, which falls within the range of 400–450 nm [38]. The spectrum (blue line) showing a peak at 410 nm was taken after 12 months of nanoparticle synthesis. This suggests that the AgNPmo retained its absorption properties over a long period of time. Therefore, in terms of nanoparticle stability and synthesis longevity, our UV-Vis spectral consistency over 12 months correlates with reports by Asif et al. (2022) [36], who highlighted the extended shelf-life and consistent absorbance properties of plant-derived AgNPs synthesized using Moringa oleifera. Similarly, previous studies have observed agglomeration in SEM images without loss of biological activity, a phenomenon mirrored in our findings and suggesting the functional resilience of biosynthesized nanoparticles despite morphological heterogeneity Moodley et al. (2018) [35]. The molecular interaction of the synthesized nanoparticles could be attributed to the surface plasmon resonance (SPR) due to the interaction of the free electrons found in metal-based synthesized nanoparticles with light energy [39].

The FTIR analysis in Fig 2 revealed the functional groups corresponding to absorbance peaks, which are interpreted according to the spectra correlation table [40]. The peaks, wavenumber (cm-1), and their indication are represented in Table 1. The spectra suggest that the biomolecule compounds in the M. Oleifera leaf extract act by reducing the Ag ions through interaction with biomolecule functional groups and thus function as capping agents in the formation of the AgNPmo within a uniform size and shape [41]. Additionally our FTIR data confirm the presence of functional groups associated with phenolics and flavonoids from Moringa, supporting previous findings by Mohammed and Hawar (2022) [41], who demonstrated that plant metabolites play an essential role in both nucleation and stabilization of AgNPs. This contributes to uniformity and enhances the biological activity of the synthesized nanoparticles.

thumbnail
Table 1. FTIR analysis of the biosynthesized silver nanoparticles.

https://doi.org/10.1371/journal.pone.0338800.t001

thumbnail
Fig 2. FTIR spectrum of biosynthesized silver nanoparticles (AgNPmo).

Major absorption bands were observed as stated in Table 1. These functional groups suggest the presence of phytochemicals from Moringa oleifera extract that act as reducing and stabilizing agents during nanoparticle synthesis.

https://doi.org/10.1371/journal.pone.0338800.g002

SEM analysis of the AgNPmo

The SEM analysis provided an inconclusive evaluation of the shape and size of the AgNPmo synthesized. Agglomeration of the nanoparticles was observed and associated with the purification procedure during synthesis. These results are similar to the findings of Moodley et al. (2018) [35].

The SEM analysis identifies the morphology and particle size of the nanoparticles using the microscopy technique. In Fig 3, the AgNPmo presents an irregular surface topography with different shapes and sizes. The AgNPmo was observed at 25,000 g magnification on a 3µm scale. Most of the particles aggregated, which could result from the preparation process for SEM analysis. Some of the particles (in red circles) are less than 500nm, which may indicate that tiny nanoparticles are within the agglomerated particles. SEM analysis revealed agglomerated yet functional particles, an issue frequently encountered in green synthesis methods [35] and more recently Menichetti et al. (2023) [15], emphasized that despite morphological irregularities, agglomerated AgNPs can retain strong antimicrobial activity due to their high surface reactivity and embedded functional phytochemicals.

thumbnail
Fig 3. Scanning electron microscopy showing the particle size of the biosynthesized nanoparticles.

Red circles indicate representative particles; however, due to agglomeration, size distribution was further supported by XRD analysis.

https://doi.org/10.1371/journal.pone.0338800.g003

XRD analysis of the AgNPmo

The XRD analysis is a good indication of the crystalline structure and stability of nanoparticles. The AgNPmo synthesized, confirmed by the XRD pattern (Fig 4), showed diffraction spectra of 27.91°, 32.37°, and 38.30°. 44.41°, 46.20°, thus revealing the crystalline nature of the synthesized nanoparticles [42]. The diffractogram peaks at 32.37°, 38.30°. 44.41° corresponds to peaks (100), (111), and (200) crystallographic planes when compared with the standard powder diffraction card of the Joint Committee on Powder Diffraction Standards (JCPDS) (Fig 4) [43].

The crystalline nature of our nanoparticles is critical because crystallinity has been correlated with enhanced biological reactivity. Similar crystalline diffraction patterns have been noted in comparable studies on biosynthesized AgNPs used for antimicrobial and antiviral applications [20].

Analysis of antimicrobial activity

Exposure of clinical bacterial pathogens to AgNPs has been reported to disrupt membrane permeability, prompting leakage from cells and hindering their growth and replication [4446]. First, to confirm the efficacy of the synthesized silver nanoparticles, the antibacterial activities of the AgNPmo were carried out on Pseudomonas aeruginosa and Staphylococcus aureus clinical isolates (Fig 5A and 5B). The effectiveness of AgNPs extracted from Moringa oleifera against the tested bacterial strains was evident in the susceptibility of P. aeruginosa, showing a notable sensitivity with a mean zone of inhibition (ZOI) diameter of 15.5, 11, 7.5, and 6.5 mm at AgNPmo concentrations of 100% (1.68 mg/mL), 50, 25 and 12.5%, respectively (Fig 5C). Similarly, for S. aureus, a lesser mean ZOI diameter of 7.0, 4, 3.5, and 0 mm at similar concentrations of the AgNPmo, respectively (Fig 5D). The NC (negative control) containing DMSO without the AgNPmo showed no effect on the bacterial isolates, confirming the antimicrobial activity of the synthesized nanoparticles (Figure in S1 Fig). The result suggests a direct correlation between the quantity of AgNPs and the expansion of the ZOI. In agreement with our study, some reports have documented the action of AgNPs against bacterial proliferation in a concentration-dependent manner [47,48]. The AgNPmo demonstrated dose-dependent inhibition against P. aeruginosa and S. aureus, with the former showing greater susceptibility. This is consistent with reports by Ferreres et al. (2023) [48], who found that Gram-negative bacteria, due to thinner peptidoglycan layers, are more vulnerable to the oxidative stress induced by AgNPs. Ultimately, AgNPs interfere with bacterial macromolecules, causing breakdown and eventual cell death. Our observed trend—larger inhibition zones with increasing AgNPmo concentrations—parallels the concentration-dependent action described by Tripathi and Goshisht (2022) [44].

thumbnail
Fig 5. Antibacterial activities of the AgNPmo.

Zone of Inhibition (ZOI) of P. aeruginosa and S. aureus, respectively, at different concentrations of the AgNPmo in (5A) and (5B). Dose-dependent increase in ZOI for P. aeruginosa (5C) and S. aureus (5D). Negative control (NC) contains DMSO only.

https://doi.org/10.1371/journal.pone.0338800.g005

Cytotoxicity assay

After confirming the efficacy of the AgNPmo by evaluating its antimicrobial activity against clinical bacterial isolates, the cytotoxicity effect on VERO cells was evaluated to determine the inhibitory concentration (IC50) for the subsequent antiviral study. The results revealed that the AgNPmo exhibited significant cytotoxic activities in a dose-dependent manner (Fig 6).

thumbnail
Fig 6. Percentage cell viability Vero cells treated with the 10mM biosynthesized silver nanoparticles at different concentrations.

Cells were cultured for 24 h prior to treatment. At high concentrations (>312.5 µg/mL), AgNPmo caused marked cytotoxicity.

https://doi.org/10.1371/journal.pone.0338800.g006

The statistical analysis performed on data derived from the CCK-8 assay revealed an IC50 value of 38 µg/mL for the 10mM stock concentration of the AgNPmo compared to the control, indicating relatively low cytotoxicity at effective concentrations. At higher doses (> 312.5 µg/mL), the assay showed negative viability values, reflecting high cytotoxicity. These findings suggest that while AgNPmo is biocompatible at low to moderate concentrations, excessive doses can disrupt cell integrityThe viability of untreated Vero cells (control) remained unchanged at 100% cell viability. The IC50 value in this study is lower compared to a previous study, which reported a 568 g/mL IC50 of AgNPs biosynthesized using Catharanthus roseus [49]. The low IC50 value indicates a minimal inhibitory effect on the viability of Vero cells, making AgNPmo biocompatible with human cells. Vero cells were used for cytotoxicity assays because they are a well-established model for preliminary screening of nanoparticle toxicity and are routinely used in SARS-CoV-2 research. Direct cytotoxicity assays on SARS-CoV-2-infected cells require BSL-3 facilities, which were beyond the scope of this study. This finding supports the potential of synthesized AgNPmo for safe environmental applications, especially in water treatment scenarios.

Quantitative RT-PCR analysis

Quantitative PCR (qPCR) assay is a primary method of detecting the viral load of SARS-CoV-2 in various clinical specimens, including nasopharyngeal swabs stored in viral transport medium, sputum, and saliva [50]. The qPCR assay targets the viral RNA, which is extracted from the clinical sample and reverse transcribed into complementary DNA (cDNA). The cDNA is then amplified using specific primers and fluorescent probes that target specific regions of the SARS-CoV-2 genome, majorly the structural proteins. The results of the qPCR for SARS-CoV-2 detection are reported as cycle threshold (Ct) values, which indicate the presence or absence of the target genes [51]. The lower the Ct value, the higher the viral load in the clinical sample; a Ct value of less than 35 is considered positive for SARS-CoV-2, indicating the presence of viral RNA in the sample, while a low Ct value of less than 20 indicates a high viral load, while a high Ct value more than 30 indicates a low viral load.

This study explored the virucidal effect of biosynthesized silver nanoparticles against the SARS-CoV-2 virus at non-toxic concentrations using qPCR. To assess the dose-dependent effect of the synthesized AgNPmo on SARS-CoV-2 in a viral transport medium (VTM), the VTM was incubated with the biosynthesized AgNPmo over a period of 2 days at 24-hour intervals. The sample controls (SC) were included to confirm whether the increase in the Ct values is due to the activity of AgNPmo on the virus or environmental conditions, such as temperature, change in incubation time, or error in the viral RNA extraction or qPCR setup.

Figs 7 and 8 represent the cycle threshold (Ct) values of the target SARS-CoV-2 genes (ORF-Lab1ab and N-genes), respectively, against the AgNPmo dilutions. Starting with the IC50 concentration from the cytotoxicity assay, the AgNPmo had a similar progressive inhibitory effect at all the concentrations for both target genes. The inhibitory effect of the AgNPmo was also time-dependent, while the Ct values increased with an increase in the hours of incubation. The Ct values for the sample controls (SC) remained steady over the incubation period. A slight upward trend was observed in the inhibitory effect of the AgNPmo with a decrease in the nanoparticle concentration for both genes (Fig 7 and 8). However, at 4.25 µg/mL concentration, there was no significant increase in the Ct values at 0 and 24 hours of incubation. The rapid increase in the inhibitory effect of AgNPmo on SARS-CoV-2 at 48 hours may be due to the long-time of incubation, which could have allowed the AgNPmo to interact well with the viral particles. The antiviral effect was evidenced by a progressive increase in Ct values with increasing incubation time. At 48 h, the Ct values rose significantly compared to controls, confirming inhibition of viral replication. This time- and dose-dependent effect provides direct evidence for the antiviral activity of AgNPmo.The most compelling result of our study is the increase in Ct values after 48 hours of exposure to AgNPmo, suggesting a strong inhibitory effect on SARS-CoV-2 replication. This observation supports the hypothesis proposed by Ratan et al. (2021) [32] and recently reviewed by Luceri et al. (2023) [20], who noted that AgNPs interfere with the integrity of viral envelopes, inhibit fusion with host membranes, and disrupt genome replication.

thumbnail
Fig 7. Inhibitory effect of the biosynthesized nanoparticles against SARS-CoV-2 ORF-Lab 1 gene.

Sample control (SC) is the positive control. Bars represent mean ± SEM of duplicate experiments. *p < 0.05 compared to SC.

https://doi.org/10.1371/journal.pone.0338800.g007

thumbnail
Fig 8. Inhibitory effect of the biosynthesized nanoparticles against SARS-CoV-2 N-gene.

Sample control (SC) is the positive control. Bars represent mean ± SEM of duplicate experiments. *p < 0.05 compared to SC.

https://doi.org/10.1371/journal.pone.0338800.g008

Therefore, the increase in Ct-values observed in this study may result from the AgNPmo interacting with viral replication, thereby inhibiting the viral RNA synthesis or assembly of viral particles. The AgNPmo might also have interfered with the structural proteins and inhibited their ability to bind with cell receptors or the genetic material of viruses, thereby inhibiting viral replication at the optimal concentration [52].

Baghban et al. (2024) [33] demonstrated that metallic nanoparticles can be particularly effective when allowed to undergo extended incubation with viral particles, supporting our time-dependent virucidal findings. The observation that lower concentrations (9.5 µg/mL) were still effective also suggests potential for safe application at low doses.

The beneficial effects of AgNPmo may be attributed to phytochemicals in Moringa oleifera leaves, particularly flavonoids and phenolic compounds, which serve as natural reducing and capping agents. These compounds enhance nanoparticle stability and may synergize with AgNPs by contributing to antioxidant and antimicrobial activities. Mechanically, AgNPs are known to disrupt viral envelopes, interfere with receptor binding, and induce oxidative stress in microbial cells. Together, these effects explain the observed antimicrobial and antiviral outcomes.

Our findings are relevant in light of emerging evidence linking SARS-CoV-2 transmission to water systems. Studies have emphasized the need to identify affordable and scalable technologies for viral decontamination in wastewater. Our data demonstrate that AgNPmo is a viable candidate: it is low-cost, environmentally friendly, and exhibits potent virucidal effects without harming eukaryotic cells at effective concentrations.

In summary, this study showed that the biogenic silver nanoparticles were effective in inhibiting SARS-CoV-2. The virus inside the VTM showed an increase in Ct values, indicating a reduction in the virus’s effectiveness. The results suggest that the nanoparticles are also relatively safe at controlled concentrations. The findings from this study are valuable and can be repurposed as a cost-effective and less toxic method of degrading SARS-CoV-2 particles in environmental water samples. Our approach, which utilizes inexpensive Moringa leaves and rapid microwave synthesis, aligns with reports that green AgNP production can cost approximately £8 per gram, compared to £18–28 per gram for commercial AgNPs [53]. This supports the potential cost-effectiveness of AgNPmo, though a direct economic evaluation in our system remains necessary.

While this study provides promising insights into the antiviral properties of Moringa-synthesized silver nanoparticles (AgNPmo), it has some limitations: 1) all experiments were conducted under in vitro conditions using Vero cells and viral transport medium, which do not fully replicate the complexity of real environmental or physiological systems. Consequently, the efficacy and safety of AgNPmo in actual water treatment settings or in vivo models have not been tested. 2) Although the increase in qPCR cycle threshold (Ct) values suggests viral inhibition, the exact molecular mechanism by which AgNPmo exerts its antiviral effect against SARS-CoV-2 was not elucidated. 3) This study was limited to a single viral strain, without evaluating other SARS-CoV-2 variants or unrelated enveloped viruses; this restricts the generalizability of the findings. 4) While cytotoxicity was assessed in mammalian cells, no environmental toxicity studies were performed to evaluate the potential risks of AgNPmo release into ecosystems. 5) The cytotoxicity data in this study were obtained using the CCK-8 colorimetric assay, which measures cellular metabolic activity rather than direct cell counts. Metallic nanoparticles can interfere with colorimetric reagents by absorbing/scattering light or chemically interacting with the dye; to mitigate this, we included NP-only control wells and subtracted their absorbance from treated wells. Negative corrected viability values observed at very high nanoparticle concentrations likely reflect a combination of severe cytotoxicity and assay interference; future work should confirm these observations with orthogonal assays (LDH release, ATP assays) and microscopy. 6) Finally, although UV-Vis data indicated some long-term absorbance stability, a comprehensive analysis of shelf-life and storage conditions for practical deployment was not conducted. These limitations highlight the need for further in vivo, environmental, and mechanistic studies prior to field application.

Materials and methods

Collection of Plant material and preparation of extract

Fresh Moringa oleifera leaves were obtained from the gardens of the Redeemer’s University, Ede, Osun State, Nigeria. Mr. Olusegun Adedeji of the Biological Sciences Department at the Redeemer’s University identified and authenticated the plant leaf material, and a voucher specimen (MO-01/2023) was put in the herbarium for referencing. The leaves were rinsed thoroughly with distilled and deionized water to remove dust particles. 20g of fresh leaf samples were submerged in 100 mL of deionized water. The mixture was heated using a microwave for 1 minute until a yellow-green coloration was observed. The crude extract was allowed to cool for 10 minutes, then filtered using Whatman® Number 1 filter paper. The filtered leaf extract was then stored in a refrigerator at 4°C for further use.

Green synthesis of silver nanoparticles

The silver nanoparticles were synthesized using a mixture of the aqueous leaf extract and 10 mM silver nitrate (AgNO3) solution (BDH Chemicals, UK) prepared in deionized water. The constant microwave irradiation method was used for the nanoparticle synthesis [54]. Briefly, AgNO3 solution and leaf extract were mixed at a ratio of 9:1, respectively. The solution was covered using a microwave-safe cling wrap and irradiated in a microwave oven operating at 400 watts for 30 seconds. The solution was allowed to stand for 5 minutes until reddish-brown coloration was observed. The overall silver nanoparticle synthesis (AgNPmo) progressed from a light yellow to a dark reddish-brown coloration.

The AgNPmo were purified by centrifugation at 1,500 rpm for 15 minutes at 4°C to avoid damaging the nanoparticles or altering their physicochemical properties. The supernatant was then discarded; the pellet was washed with deionized water, and the process was repeated. The resultant paste was dried overnight in a hot air oven at 25°C.

Physicochemical characterization of silver nanoparticles

After visible coloration, the formation of the nanoparticle was first analyzed using UV-Vis spectrophotometry. The absorption spectra of the nanoparticles were analyzed within 350–500 nm wavelength using JENWAY 7305a spectrophotometer (Bibby Scientific, UK). The dried nanoparticle was diluted with distilled water, and UV-Vis spectrophotometry was repeated using nanodrop 2000 (Thermofisher, UK) after one year of synthesis. A Fourier Transform Infrared (FT-IR) spectrophotometer (Bruker, UK) and a KBr pellet method were used to determine biomolecules or functional groups responsible for the reduction and capping of the prepared AgNPmo nanoparticles within the spectral range of 3500–500 cm-1.

X-ray Diffraction (XRD) analysis was performed using a D2 phaser x-ray diffractometer (Bruker, UK) with a Cu Kα radiation source in the 10°-60° 2θ range, 0.02°/s scanning step size. A smooth powder surface was placed in the sample holder with the primary divergent slit confirmed as 1 mm before closing the machine. The XRD machine was closed to avoid contact with the emitted radiation. The data was then transferred to the ICDD PDF-4 + software for phase analysis. Using Scanning Electron Microscopy (SEM) to estimate the dimensions of AgNPmo, the grain morphology was collected using an FEI Inspect F Scanning Electron Microscope (TSS Microscopy, USA). Before SEM analyses, the sample was coated with carbon to make the surface conductive to enable a better signal and good image under the microscope. The SEM was performed at an accelerating voltage of 10–15.0 kV, a spot size of 3.5–4.0, and a variable working distance.

Antibacterial activity

Antibacterial activities of the AgNPs extract of Moringa oleifera leaves were carried out using agar well diffusion and the Minimum Inhibitory Concentration (MIC) method on Pseudomonas aeruginosa (ATCC 154423) and Staphylococcus aureus (ATCC 209233) clinical isolates. The isolates were obtained from the stock in the microbiology department at Redeemer’s University. Bacteria suspension of each isolate (1.5 x 108 cells/mL) was prepared and compared with 0.5 McFarland standard, which was aseptically swabbed on a Mueller Hinton Agar plate with a sterile swab stick. Diffusion wells were made using a sterile cork borer (6 mm in diameter) and placed into the agar plates. Different concentrations of the AgNPmo, 100% (1.68 mg/mL), 50% (0.84 mg/mL), 25% (0.42 mg/mL), and 12.5% (0.21 mg/mL) prepared with 1% DMSO in two-fold serial dilution. 100 µl of each concentration was dispensed into each well labeled accordingly. The experiment was carried out in duplicate, and the plates were placed in the refrigerator for 30 minutes to allow the extract to diffuse into the agar. The plates were then incubated for 24h at 37°C.

Cytotoxicity assay

The Cell viability test of the synthesized AgNPmo was analyzed through a Cell Counting Kit-8 (CCK-8) on Vero cells. The Vero cells (2 × 105) were seeded into each well of a 96-well plate and cultured for 24 hours before any treatment. The AgNPmo treatment groups were administered serial dilutions of the stock solution from 5 mg/mL to 0 mg/mL.10 µl CCK-8 reagent was added, and after 3 hours of incubation under humidified conditions at 37°C, the color development of the samples was measured at a test wavelength of 450 nm and a reference wavelength of 630 nm using an 800 TS microplate reader (Biotek Instruments, USA). The experiment was done in duplicate.

The relative cell viability was calculated as follows:

The half maximal inhibitory concentration (IC50) was calculated using the statistics software Graph Prism version 9.

Quantitative RT-PCR assay for antiviral activity

The COVID-19-positive samples preserved inside the Viral Transport Medium (VTM) were used for the experiment. The samples used were obtained from the Nigeria Institute of Medical Research (NIMR), and the ethical approval (IRB/23/029) was obtained from the ethical committee of the institute’s reviewers’ board. Verbal consent was obtained from the patient whose SARS-CoV-2-positive sample was used for this study.

AgNPmo stock concentration was diluted serially with sterile VTM to make 38, 19, 9.5, and 4.75 µg/mL based on the IC50 report from the cytotoxicity assay. 100 µl of each dilution was mixed with 100 µl SARS-CoV-2 contaminated VTM and incubated for two days (0, 24, and 48 hours) at 25°C with periodic shaking. Viral RNA was extracted using the Qiagen RNA nucleic acid extraction kit (Qiagen, Hilden, Germany) at 0-, 24-, and 48-hour intervals. 60µl of the viral RNA was eluted after dry spinning the column for 2 minutes.

The quantitative RT-PCR was performed using the SCODA SARS-CoV-2 Fast PCR assay protocol according to Shaibu et al. (2023) [55]. The final reaction mixture of 25µl contained 7µl of the SCODA reagent A, 13µl of the SCODA reagent B, and 5µl of each sample. PCR amplification was achieved using a QuantStudio™ 5 Real-Time PCR System (ThermoFisher Scientific, UK) at optimized PCR conditions of 52˚C for 10 minutes, 95˚C for 10 seconds, 95˚C for 5 seconds (40 cycles) and 56˚C for 30 seconds (40 cycles). The reaction was performed in duplicate. Three controls were set up: First, the sample control (SC) contained the reaction mixture without AgNPmo. The negative control (NC) contained the reaction mixture and RNAse-free water without the sample. The third control contained the qPCR kit positive control (PC), replacing the sample. Both the NC and PC are used to control the quality of the PCR process.

Inclusivity in global research

Additional information regarding the ethical, cultural, and scientific considerations specific to inclusivity in global research is included in the Supporting Information (S8 Checklist).

Statistical analysis

Arithmetic mean and standard error were calculated for the antimicrobial and antiviral experiments. Statistical analysis was performed using GraphPad Prism version 9 (GraphPad Software, USA). One-way ANOVA was applied to compare treated groups with controls, and p-values < 0.05 were considered statistically significant.

Supporting information

S1 Fig. Showing negative control (NC) containing DMSO without the AgNPmo.

https://doi.org/10.1371/journal.pone.0338800.s001

(PDF)

S2 Fig. Visual observation of AgNPmo synthesis showing the progressive color change of the reaction mixture (a) 0 min – yellowish prior to nanoparticle formation, (b) 5 min – brown indicating onset of nanoparticle formation, and (c) 10 min – reddish brown brown corresponding to complete AgNP formation.

https://doi.org/10.1371/journal.pone.0338800.s002

(PDF)

S3 Table. Values for the cytotoxicity assay.

https://doi.org/10.1371/journal.pone.0338800.s005

(PDF)

S4 Table. Zone of Inhibition (ZOI) of P. aeruginosa at different concentrations of the AgNPmo.

https://doi.org/10.1371/journal.pone.0338800.s006

(PDF)

S5 Table. Zone of Inhibition (ZOI) of S. aureusat different concentrations of the AgNPmo.

https://doi.org/10.1371/journal.pone.0338800.s007

(PDF)

S6 Table. Inhibitory effect of the biosynthesized nanoparticles against SARS-CoV-2 N-gene.

https://doi.org/10.1371/journal.pone.0338800.s008

(PDF)

S7 Table. Inhibitory effect of the biosynthesized nanoparticles against SARS-CoV-2 ORF-Lab 1 gene.

https://doi.org/10.1371/journal.pone.0338800.s009

(PDF)

S9 Table. Major absorption features of AgNPmo identified from UV–Vis spectrophotometry.

https://doi.org/10.1371/journal.pone.0338800.s011

(PDF)

References

  1. 1. Chintagunta AD, M SK, Nalluru S, N S SK. Nanotechnology: an emerging approach to combat COVID-19. Emergent Mater. 2021;4(1):119–30. pmid:33615141
  2. 2. Shittu MO, Afolami OI. Improving the efficacy of Chloroquine and Hydroxychloroquine against SARS-CoV-2 may require Zinc additives - A better synergy for future COVID-19 clinical trials. Infez Med. 2020;28(2):192–7. pmid:32335560
  3. 3. Guo Y-R, Cao Q-D, Hong Z-S, Tan Y-Y, Chen S-D, Jin H-J, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020;7(1):11. pmid:32169119
  4. 4. Bhowmick GD, Dhar D, Nath D, Ghangrekar MM, Banerjee R, Das S, et al. Coronavirus disease 2019 (COVID-19) outbreak: some serious consequences with urban and rural water cycle. npj Clean Water. 2020;3(1).
  5. 5. Tran HN, Le GT, Nguyen DT, Juang R-S, Rinklebe J, Bhatnagar A, et al. SARS-CoV-2 coronavirus in water and wastewater: A critical review about presence and concern. Environ Res. 2021;193:110265. pmid:33011225
  6. 6. Girón-Navarro R, Linares-Hernández I, Castillo-Suárez LA. The impact of coronavirus SARS-CoV-2 (COVID-19) in water: potential risks. Environ Sci Pollut Res Int. 2021;28(38):52651–74. pmid:34453253
  7. 7. Sodhi KK, Singh CK. A systematic review on the occurrence, fate, and remediation of SARS-CoV-2 in wastewater. Int J Environ Sci Technol (Tehran). 2023;20(7):8073–86. pmid:35755183
  8. 8. Amin N, Haque R, Rahman MZ, Rahman MZ, Mahmud ZH, Hasan R, et al. Dependency of sanitation infrastructure on the discharge of faecal coliform and SARS-CoV-2 viral RNA in wastewater from COVID and non-COVID hospitals in Dhaka, Bangladesh. Sci Total Environ. 2023;867:161424. pmid:36623655
  9. 9. Islam MA, Rahman MA, Jakariya M, Bahadur NM, Hossen F, Mukharjee SK, et al. A 30-day follow-up study on the prevalence of SARS-COV-2 genetic markers in wastewater from the residence of COVID-19 patient and comparison with clinical positivity. Sci Total Environ. 2023;858(Pt 3):159350. pmid:36265620
  10. 10. Eloffy MG, El-Sherif DM, Abouzid M, Elkodous MA, El-nakhas HS, Sadek RF, et al. Proposed approaches for coronaviruses elimination from wastewater: Membrane techniques and nanotechnology solutions. Nanotechnology Reviews. 2021;11(1):1–25.
  11. 11. Pal S, Tak YK, Song JM. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Escherichia coli. Appl Environ Microbiol. 2007;73(6):1712–20. pmid:17261510
  12. 12. Anwar Z, Ali SA, Shah MR, Ahmed F, Ahmed A, Ijaz U, et al. Photochemical preparation, characterization and formation kinetics of riboflavin conjugated silver nanoparticles. Journal of Molecular Structure. 2023;1289:135863.
  13. 13. Tang S, Zheng J. Antibacterial Activity of Silver Nanoparticles: Structural Effects. Adv Healthc Mater. 2018;7(13):e1701503. pmid:29808627
  14. 14. Bello AJ, Adams LA, Onyejepu NN, Igbinehi JI, Igbari OF, Okpuzor J. Biogenic nanosilver inhibits <i>Mycobacteria</i> using nitrate reductase assay. IJNBM. 2019;8(2):129.
  15. 15. Menichetti A, Mavridi-Printezi A, Mordini D, Montalti M. Effect of Size, Shape and Surface Functionalization on the Antibacterial Activity of Silver Nanoparticles. J Funct Biomater. 2023;14(5):244. pmid:37233354
  16. 16. Elgorban AM, El-Samawaty AE-RM, Yassin MA, Sayed SR, Adil SF, Elhindi KM, et al. Antifungal silver nanoparticles: synthesis, characterization and biological evaluation. Biotechnology & Biotechnological Equipment. 2016;30(1):56–62.
  17. 17. Matras E, Gorczyca A, Przemieniecki SW, Oćwieja M. Surface properties-dependent antifungal activity of silver nanoparticles. Sci Rep. 2022;12(1):18046. pmid:36302952
  18. 18. Galdiero S, Falanga A, Vitiello M, Cantisani M, Marra V, Galdiero M. Silver nanoparticles as potential antiviral agents. Molecules. 2011;16(10):8894–918. pmid:22024958
  19. 19. Salleh A, Naomi R, Utami ND, Mohammad AW, Mahmoudi E, Mustafa N, et al. The Potential of Silver Nanoparticles for Antiviral and Antibacterial Applications: A Mechanism of Action. Nanomaterials (Basel). 2020;10(8):1566. pmid:32784939
  20. 20. Luceri A, Francese R, Lembo D, Ferraris M, Balagna C. Silver Nanoparticles: Review of Antiviral Properties, Mechanism of Action and Applications. Microorganisms. 2023;11(3):629. pmid:36985203
  21. 21. Anselmo AC, Mitragotri S. Nanoparticles in the clinic. Bioeng Transl Med. 2016;1(1):10–29. pmid:29313004
  22. 22. Singh L, Kruger HG, Maguire GEM, Govender T, Parboosing R. The role of nanotechnology in the treatment of viral infections. Ther Adv Infect Dis. 2017;4(4):105–31. pmid:28748089
  23. 23. Tripathi DK, Tripathi A, Shweta, Singh S, Singh Y, Vishwakarma K, et al. Uptake, Accumulation and Toxicity of Silver Nanoparticle in Autotrophic Plants, and Heterotrophic Microbes: A Concentric Review. Front Microbiol. 2017;8:07. pmid:28184215
  24. 24. Peñalver R, Martínez-Zamora L, Lorenzo JM, Ros G, Nieto G. Nutritional and Antioxidant Properties of Moringa oleifera Leaves in Functional Foods. Foods. 2022;11(8):1107. pmid:35454694
  25. 25. van den Berg J, Kuipers S. The antibacterial action of Moringa oleifera: A systematic review. South African Journal of Botany. 2022;151:224–33.
  26. 26. Erjaee H, Rajaian H, Nazifi S. Synthesis and characterization of novel silver nanoparticles using Chamaemelum nobile extract for antibacterial application. Adv Nat Sci: Nanosci Nanotechnol. 2017;8(2):025004.
  27. 27. Singh J, Kaur H, Rawat M. An uncanny potential of plants for metal nanoparticles synthesis. J Nanomed Res. 2018;7(3):228–9.
  28. 28. Shyam A, Chandran S S, George B, E S. Plant mediated synthesis of AgNPs and its applications: an overview. Inorganic and Nano-Metal Chemistry. 2020;51(12):1646–62.
  29. 29. Khan F, Shariq M, Asif M, Siddiqui MA, Malan P, Ahmad F. Green Nanotechnology: Plant-Mediated Nanoparticle Synthesis and Application. Nanomaterials (Basel). 2022;12(4):673. pmid:35215000
  30. 30. Khandel P, Shahi SK, Soni DK, Yadaw RK, Kanwar L. Alpinia calcarata: potential source for the fabrication of bioactive silver nanoparticles. Nano Converg. 2018;5(1):37. pmid:30519797
  31. 31. Parida VK, Saidulu D, Bhatnagar A, Gupta AK, Afzal MS. A critical assessment of SARS-CoV-2 in aqueous environment: Existence, detection, survival, wastewater-based surveillance, inactivation methods, and effective management of COVID-19. Chemosphere. 2023;327:138503. pmid:36965534
  32. 32. Ratan ZA, Mashrur FR, Chhoan AP, Shahriar SM, Haidere MF, Runa NJ, et al. Silver Nanoparticles as Potential Antiviral Agents. Pharmaceutics. 2021;13(12):2034. pmid:34959320
  33. 33. Baghban N, Momeni S, Behboudi E, Dianat-Moghadam H, Darabi A, Targhi HS, et al. Green synthesis of MnO2 NPs using Arabic gum: assessing its potential antiviral activity against influenza A/H1N1. Virol J. 2024;21(1):48. pmid:38395943
  34. 34. Maduray K, Moodley R, Ramdhani S, Parboosing R. The anti-HIV activity of biogenic silver nanoparticles synthesized from Centella asiatica extracts. Journal of Herbal Medicine. 2022;35:100592.
  35. 35. Moodley JS, Krishna SBN, Pillay K, Sershen, Govender P. Green synthesis of silver nanoparticles from Moringa oleifera leaf extracts and its antimicrobial potential. Adv Nat Sci: Nanosci Nanotechnol. 2018;9(1):015011.
  36. 36. Asif M, Yasmin R, Asif R, Ambreen A, Mustafa M, Umbreen S. Green Synthesis of Silver Nanoparticles (AgNPs), Structural Characterization, and their Antibacterial Potential. Dose Response. 2022;20(1):15593258221088709. pmid:35592270
  37. 37. Jain N, Jain P, Rajput D, Patil UK. Green synthesized plant-based silver nanoparticles: therapeutic prospective for anticancer and antiviral activity. Micro and Nano Syst Lett. 2021;9(1).
  38. 38. Gupta S, Bisht SA, Kelkar-Mane V. Assessing the enzyme modulating and antimicrobial efficiency of moringa capped silver nanoparticles for their potential use as fodder supplement. Res J Life Sci Bioinform Pharm Chem Sci. 2019;5(02):927–38.
  39. 39. Hamouda RA, Hussein MH, Abo-Elmagd RA, Bawazir SS. Synthesis and biological characterization of silver nanoparticles derived from the cyanobacterium Oscillatoria limnetica. Sci Rep. 2019;9(1):13071. pmid:31506473
  40. 40. Mecozzi M, Pietroletti M, Scarpiniti M, Acquistucci R, Conti ME. Monitoring of marine mucilage formation in Italian seas investigated by infrared spectroscopy and independent component analysis. Environ Monit Assess. 2012;184(10):6025–36. pmid:22020392
  41. 41. Mohammed GM, Hawar SN. Green Biosynthesis of Silver Nanoparticles from Moringa oleifera Leaves and Its Antimicrobial and Cytotoxicity Activities. Int J Biomater. 2022;2022:4136641. pmid:36193175
  42. 42. Hussain M, Raja NI, Mashwani Z-U-R, Naz F, Iqbal M, Aslam S. Green synthesis and characterisation of silver nanoparticles and their effects on antimicrobial efficacy and biochemical profiling in Citrus reticulata. IET Nanobiotechnol. 2018;12(4):514–9. pmid:29768240
  43. 43. Rudrappa M, Rudayni HA, Assiri RA, Bepari A, Basavarajappa DS, Nagaraja SK, et al. Plumeria alba-Mediated Green Synthesis of Silver Nanoparticles Exhibits Antimicrobial Effect and Anti-Oncogenic Activity against Glioblastoma U118 MG Cancer Cell Line. Nanomaterials (Basel). 2022;12(3):493. pmid:35159838
  44. 44. Tripathi N, Goshisht MK. Recent Advances and Mechanistic Insights into Antibacterial Activity, Antibiofilm Activity, and Cytotoxicity of Silver Nanoparticles. ACS Appl Bio Mater. 2022;5(4):1391–463. pmid:35358388
  45. 45. Wahab S, Salman A, Khan Z, Khan S, Krishnaraj C, Yun S-I. Metallic Nanoparticles: A Promising Arsenal against Antimicrobial Resistance-Unraveling Mechanisms and Enhancing Medication Efficacy. Int J Mol Sci. 2023;24(19):14897. pmid:37834344
  46. 46. Anyaegbunam NJ, Mba IE, Ige AO, Ogunrinola TE, Emenike OK, Uwazie CK, et al. Revisiting the smart metallic nanomaterials: advances in nanotechnology-based antimicrobials. World J Microbiol Biotechnol. 2024;40(3):102. pmid:38366174
  47. 47. Wirth SM, Bertuccio AJ, Cao F, Lowry GV, Tilton RD. Inhibition of bacterial surface colonization by immobilized silver nanoparticles depends critically on the planktonic bacterial concentration. J Colloid Interface Sci. 2016;467:17–27. pmid:26771749
  48. 48. Ferreres G, Ivanova K, Torrent-Burgués J, Tzanov T. Multimodal silver-chitosan-acylase nanoparticles inhibit bacterial growth and biofilm formation by Gram-negative Pseudomonas aeruginosa bacterium. J Colloid Interface Sci. 2023;646:576–86. pmid:37210905
  49. 49. Jamil K, Khattak SH, Farrukh A, Begum S, Riaz MN, Muhammad A, et al. Biogenic Synthesis of Silver Nanoparticles Using Catharanthus roseus and Its Cytotoxicity Effect on Vero Cell Lines. Molecules. 2022;27(19):6191. pmid:36234756
  50. 50. Ahmadzadeh M, Vahidi H, Mahboubi A, Hajifathaliha F, Nematollahi L, Mohit E. Different Respiratory Samples for COVID-19 Detection by Standard and Direct Quantitative RT-PCR: A Literature Review. Iran J Pharm Res. 2021;20(3):285–99. pmid:34903989
  51. 51. Udugama B, Kadhiresan P, Kozlowski HN, Malekjahani A, Osborne M, Li VY. Diagnosing COVID-19: the disease and tools for detection. ACS Nano. 2020;14(4):3822–35.
  52. 52. Zhang X-F, Liu Z-G, Shen W, Gurunathan S. Silver Nanoparticles: Synthesis, Characterization, Properties, Applications, and Therapeutic Approaches. Int J Mol Sci. 2016;17(9):1534. pmid:27649147
  53. 53. Rocha V, Ferreira-Santos P, Aguiar C, Neves IC, Tavares T. Valorization of plant by-products in the biosynthesis of silver nanoparticles with antimicrobial and catalytic properties. Environ Sci Pollut Res Int. 2024;31(9):14191–207. pmid:38278998
  54. 54. Ashraf H, Anjum T, Riaz S, Naseem S. Microwave-Assisted Green Synthesis and Characterization of Silver Nanoparticles Using Melia azedarach for the Management of Fusarium Wilt in Tomato. Front Microbiol. 2020;11:238. pmid:32210928
  55. 55. Shaibu JO, Onwuamah CK, Okwuraiwe AP, Ahmed RA, Oyefolu AOB, Salako BL, et al. Performance Evaluation of Real Time Polymerase Reaction Assay (SCODA) for Detection of SARS-CoV-2. AID. 2023;13(01):21–30.